ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,877 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentGrand-LancyAdoram Therapeutics SA
Adoram Therapeutics SA Logo
Verified· 3 sources

Adoram Therapeutics SA

Summary

About the company

The core activity of Adoram Therapeutics is the development of innovative small molecules as immunotherapeutics for the treatment of solid tumors and immune-based diseases. To this end, the company leverages the benefits of allosteric biochemistry, in particular the development of allosteric modulators for adenosine receptors, to create new treatment options.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered3
Cancer immunotherapy
Small molecule immunotherapies for solid tumours, including an A2AR NAM program in preclinical testing and lead molecules advancing toward a clinical drug candidate.
Anti-inflammation drugs
Small molecule programmes targeting immune-based diseases and inflammatory or auto-immune disorders, including an A2AR PAM hit series and anti-inflammatory drug research.
Drug discovery for GPCR targets
Allosteric drug discovery for GPCR targets, using in-house know-how, curated molecule libraries and screening technology to generate new pipeline assets.
Press

Media

February 25, 2025Media
Adoram Therapeutics Secures Pre-Seed Investment
startupticker.ch

Knowledge

No knowledge articles yet

Once Adoram Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Adoram Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Adoram Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Adoram Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin des Semailles 50
1212 Grand-Lancy

At a glance

Legal form
Corporation
UID
CHE-414.015.961
Founded
2022 · 4 years
Last commercial register change
January 23, 2025
Employees
1 to 10

Similar companies

CR
CELL RECEPTOR SA
Geneva
RT
Release Therapeutics SA
Geneva
GS
GBiotech Sàrl
Chambésy
GF
Geneva Fine Art Analysis Sàrl Lancy
Les Acacias